Optimal duration of dual antiplatelet therapy following treatment with the endeavor zotarolimus-eluting stent in real-world Japanese patients with coronary artery disease (OPERA): Study design and rationale-Reference-Cited by-同舟云学术

Optimal duration of dual antiplatelet therapy following treatment with the endeavor zotarolimus-eluting stent in real-world Japanese patients with coronary artery disease (OPERA): Study design and rationale

Published:2013-12-31 Issue:3 Volume:84 Page:368-374
ISSN:1522-1946
Container-title:Catheterization and Cardiovascular Interventions
language:en
Short-container-title:Cathet. Cardiovasc. Intervent.

Author:

Nakamura Masato¹,Nanto Shinsuke²,Hirayama Atsushi³,Takayama Tadateru³,Nishikawa Masakatsu⁴,Kimura Kazuo⁵,Morita Satoshi⁶,Aizawa Tadanori⁷,Asano Ryuta⁸,Matsumaru Yuji⁹,Hamada Chikuma¹⁰,Isshiki Takaaki¹¹,

Affiliation:

1. Division of Cardiovascular Medicine; Toho University Ohashi Medical Center; Tokyo Japan

2. Department of Advanced Cardiovascular Therapeutics; Osaka University Graduate School of Medicine; Osaka Japan

3. Division of Cardiology, Department of Medicine; Nihon University School of Medicine; Tokyo Japan

4. Institute of Human Research Promotion and Drug Development; Mie University Faculty of Medicine; Tsu Japan

5. Department of Cardiology; Yokohama City University Medical Center; Yokohama Japan

6. Department of Epidemiology and Healthcare Research; Kyoto University School of Public Health; Kyoto Japan

7. Department of Cardiology; The Cardiovascular Institute Hospital; Tokyo Japan

8. Department of Cardiology; Sakakibara Memorial Hospital; Tokyo Japan

9. Department of Endovascular Neurosurgery; Toranomon Hospital; Tokyo Japan

10. Department of Management Science, Faculty of Engineering; Tokyo University of Science; Tokyo Japan

11. Department of Cardiology; Teikyo University School of Medicine; Tokyo Japan

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ccd.25282/fullpdf

Reference35 articles.

1. Stent thrombosis in randomized clinical trials of drug-eluting stents;Mauri;N Engl J Med,2007

2. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents;Kastrati;N Engl J Med,2007

3. A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents;Spaulding;N Engl J Med,2007

4. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents;Stone;N Engl J Med,2007

5. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention;Levine;A report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol,2011

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Randomized evaluation of short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: rationale and design of the REDUCE trial;American Heart Journal;2016-08

3. Thienopyridine derivatives as risk factors for bleeding following high risk endoscopic treatments: Safe Treatment on Antiplatelets (STRAP) study;Endoscopy;2015-01-15